These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1331168)

  • 1. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
    Hartung HP; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos JJ; Toyka KV
    J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector mechanisms in demyelinating neuropathies.
    Hartung HP; Zielasek J; Jung S; Toyka KV
    Rev Neurol (Paris); 1996 May; 152(5):320-7. PubMed ID: 8881423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behind the pathology of macrophage-associated demyelination in inflammatory neuropathies: demyelinating Schwann cells.
    Park HT; Kim YH; Lee KE; Kim JK
    Cell Mol Life Sci; 2020 Jul; 77(13):2497-2506. PubMed ID: 31884566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating adhesion molecules and inflammatory mediators in demyelination: a review.
    Hartung HP; Archelos JJ; Zielasek J; Gold R; Koltzenburg M; Reiners KH; Toyka KV
    Neurology; 1995 Jun; 45(6 Suppl 6):S22-32. PubMed ID: 7783908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of cytokines and other immunological mediators in neuroimmunological diseases].
    Tsukada N; Matsuda M
    Nihon Rinsho; 1994 Nov; 52(11):2899-905. PubMed ID: 7996687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic effector molecules in the pathogenesis of immune-mediated disorders of the central nervous system.
    Kieseier BC; Storch MK; Hartung HP
    J Neural Transm Suppl; 2000; 59():69-80. PubMed ID: 10961420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination: the role of reactive oxygen and nitrogen species.
    Smith KJ; Kapoor R; Felts PA
    Brain Pathol; 1999 Jan; 9(1):69-92. PubMed ID: 9989453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine macrophages stimulated with central and peripheral nervous system myelin or purified myelin proteins release inflammatory products.
    Constantinescu CS; Goodman DB; Hilliard B; Wysocka M; Cohen JA
    Neurosci Lett; 2000 Jun; 287(3):171-4. PubMed ID: 10863022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and peripheral nerve disorders.
    Créange A; Barlovatz-Meimon G; Gherardi RK
    Eur Cytokine Netw; 1997 Jun; 8(2):145-51. PubMed ID: 9262963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
    Sun L; Weng H; Li Z
    Int J Clin Exp Pathol; 2015; 8(12):15749-58. PubMed ID: 26884844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of nitric oxide production for down-regulation of CNS inflammation and demyelination.
    Brenner T; Pinto F; Abramsky O; Gallily R
    Prog Brain Res; 2001; 132():499-506. PubMed ID: 11545014
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammatory responses in aggregating rat brain cell cultures subjected to different demyelinating conditions.
    Defaux A; Zurich MG; Honegger P; Monnet-Tschudi F
    Brain Res; 2010 Sep; 1353():213-24. PubMed ID: 20638371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.
    Ledeen RW; Chakraborty G
    Neurochem Res; 1998 Mar; 23(3):277-89. PubMed ID: 9482240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of immune-mediated demyelination in the CNS.
    Hartung HP; Rieckmann P
    J Neural Transm Suppl; 1997; 50():173-81. PubMed ID: 9120417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protein composition and structure of the myelin sheath. Part I].
    Pietrucha-Dutczak M; Marcol W; Korczyńska I; Matuszek I; Górka D; Lewin-Kowalik J
    Pol Merkur Lekarski; 2003 Sep; 15(87):268-72. PubMed ID: 14679855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines and peripheral neuropathies].
    Créange A; Lefaucheur JP; Authier FJ; Gherardi RK
    Rev Neurol (Paris); 1998 Apr; 154(3):208-16. PubMed ID: 9773044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behaviour of oligodendrocytes and Schwann cells in an experimental model of toxic demyelination of the central nervous system.
    Graça DL; Bondan EF; Pereira LA; Fernandes CG; Maiorka PC
    Arq Neuropsiquiatr; 2001 Jun; 59(2-B):358-61. PubMed ID: 11460179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated demyelination.
    Hartung HP
    Ann Neurol; 1993 Jun; 33(6):563-7. PubMed ID: 8498835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
    Keirstead HS; Blakemore WF
    Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.